AIC
ARGS

AWM Investment Company’s Argos Therapeutics, Inc. ARGS Stock Holding History

AWM Investment Company’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-35,965
Closed -$3.49M – 115
2015
Q3 		$3.49M Sell
35,965
-1,535
-4% -$182K 0.68% 39
2015
Q2 		$5.14M Hold
37,500
– – 0.73% 47
2015
Q1 		$6.68M Hold
37,500
– – 0.92% 41
2014
Q4 		$7.5M Buy
+37,500
New +$6.74M 1.02% 35

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWM Investment Company's ARGS Position: Q4 2015 in Review

AWM Investment Company sold out of Argos Therapeutics, Inc. (ARGS) in Q4 2015, closing a stake of 35,965 shares — an estimated $3.49M sold.

AWM Investment Company first reported a position in ARGS in Q4 2014 and held it in 4 quarters. The position peaked at $7.5M in Q4 2014. 25 funds tracked by Wall St. Rank hold ARGS as of Q4 2015.

  • AWM Investment Company reported no remaining Argos Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • AWM Investment Company sold 35,965 Argos Therapeutics, Inc. shares in Q4 2015, an estimated $3.49M.
  • AWM Investment Company first reported a position in Argos Therapeutics, Inc. in Q4 2014 and held it in 4 quarters.
  • AWM Investment Company's Argos Therapeutics, Inc. position peaked at $7.5M in Q4 2014.
  • 25 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2015.

Based on AWM Investment Company's 13F filing for Q4 2015, filed 8 Feb 2016.